Latest News
A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024
- April 23, 2024
Yale scientists are working on an alternative treatment for COVID-19, for use in patients whose immune therapies clash with Paxlovid.
- April 23, 2024Source: LiveScience
A blood test like this would need to go through "extensive clinical trials" with thousands of patients and regulatory review, Dr. Michael Cecchini, co-director of the colorectal program at the Center for Gastrointestinal Cancers at the Yale Cancer Center who was not involved in the research, told Live Science.
- April 23, 2024Source: Oprah Daily
The rising incidence of cancer in young adults is of concern, leading clinicians to advise earlier and more frequent screenings particularly for those who have a family history of cancer. Dr. Veda Giri, MD, one of the leaders of the Yale Cancer Center's Early Onset Cancer program comments on the increase in cancer diagnosis in adults under 50. A study published in 2023 in BMJ Oncology found that rates across the globe have dramatically increased in people under the age of 50 over the past couple decades. There were 3.26 million early onset cancer cases in 2019, an increase of 79.1 percent since 1990.
- April 22, 2024
Most of us know that regular physical activity can strengthen muscles, burn fat, and lower our risk of heart disease. But many advantages of exercise go beyond physical fitness and cardiovascular health, according to Yale School of Medicine experts.
- April 22, 2024
Theranostics and Advanced Treatment Options for Prostate Cancer.
- April 22, 2024Source: Yale Medicine
Siba Haykal MD, PhD, FRCSC, FACS, is the section chief of Reconstructive Oncology for the Division of Plastic and Reconstructive Surgery within the Department of Surgery.
- April 22, 2024Source: Healthline
“Luminal B tumors are a type of hormone receptor-positive tumors that tend to be a bit more faster growing,” Dr. Maryam Lustberg, the director of the Center for Breast Cancer at Yale Cancer Center and Smilow Cancer Hospital, stated. “They are still very much driven by estrogen-based pathways as luminal A tumors but are sometimes treated with more intensive type of systemic therapies including maximal estrogen suppression, targeted therapies and sometimes chemotherapy.”
- April 19, 2024Source: The New York Times
Gastroenterologist Dr. Xavier Llor, Professor of Medicine; Director, GI and Pancreatic Cancer Prevention Program, Digestive Diseases, offers strategies to address chronic constipation.
- April 17, 2024
Camille C. R. Ragin, PhD, MPH — a member of the collaborative SPORE research program for Head and Neck Cancer at Yale — was honored with a lectureship at this year's annual meeting of the American Association for Cancer Research (AACR).